|
1
|
Dimaras H, Dimba EA and Gallie BL:
Challenging the global retinoblastoma survival disparity through a
collaborative research effort. Br J Ophthalmol. 94:1415–1416. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mahoney MC, Burnett WS, Majerovics A and
Tanenbaum H: The epidemiology of ophthalmic malignancies in New
York State. Ophthalmology. 97:1143–1147. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ortiz MV and Dunkel IJ: Retinoblastoma. J
Child Neurol. 31:227–236. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shields CL and Shields JA: Retinoblastoma
management: Advances in enucleation, intravenous chemoreduction,
and intra-arterial chemotherapy. Curr Opin Ophthalmol. 21:203–212.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Assayag F, Nicolas A, Vacher S, Dehainault
C, Bieche I, Meseure D, Aerts I, Cassoux N, Houdayer C, Doz F, et
al: Combination of Carboplatin and Bevacizumab Is an Efficient
Therapeutic Approach in Retinoblastoma Patient-Derived Xenografts.
Invest Ophthalmol Vis Sci. 57:4916–4926. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shehata HH, Abou Ghalia AH, Elsayed EK,
Ahmed Said AM and Mahmoud SS: Clinical significance of high levels
of survivin and transforming growth factor beta-1 proteins in
aqueous humor and serum of retinoblastoma patients. J AAPOS. 20:444
e1–444 e9. 2016. View Article : Google Scholar
|
|
7
|
Kivelä T: The epidemiological challenge of
the most frequent eye cancer: Retinoblastoma, an issue of birth and
death. Br J Ophthalmol. 93:1129–1131. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
de Carvalho IN, de Freitas RM and Vargas
FR: Translating microRNAs into biomarkers: What is new for
pediatric cancer? Med Oncol. 33:492016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fabian MR, Sonenberg N and Filipowicz W:
Regulation of mRNA translation and stability by microRNAs. Annu Rev
Biochem. 79:351–379. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu Y, Zhou Y, Gong X and Zhang C:
MicroRNA-30a-5p inhibits the proliferation and invasion of gastric
cancer cells by targeting insulin-like growth factor 1 receptor.
Exp Ther Med. 14:173–180. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chandra S, Vimal D, Sharma D, Rai V, Gupta
SC and Chowdhuri DK: Role of miRNAs in development and disease:
Lessons learnt from small organisms. Life Sci. 185:8–14. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jin D and Lee H: Prioritizing
cancer-related microRNAs by integrating microRNA and mRNA datasets.
Sci Rep. 6:353502016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bu W, Wang Y and Min X: MicroRNA-106b
promotes the proliferation, migration and invasion of
retinoblastoma cells by inhibiting the expression of ZBTB4 protein.
Exp Ther Med. 16:4537–4545. 2018.PubMed/NCBI
|
|
14
|
Jin Q, He W, Chen L, Yang Y, Shi K and You
Z: MicroRNA-101-3p inhibits proliferation in retinoblastoma cells
by targeting EZH2 and HDAC9. Exp Ther Med. 16:1663–1670.
2018.PubMed/NCBI
|
|
15
|
Dalgard CL, Gonzalez M, deNiro JE and
O'Brien JM: Differential microRNA-34a expression and tumor
suppressor function in retinoblastoma cells. Invest Ophthalmol Vis
Sci. 50:4542–4551. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Si W, Li Y, Shao H, Hu R, Wang W, Zhang K
and Yang Q: MiR-34a Inhibits Breast Cancer Proliferation and
Progression by Targeting Wnt1 in Wnt/β-Catenin Signaling Pathway.
Am J Med Sci. 352:191–199. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cao W, Yang W, Fan R, Li H, Jiang J, Geng
M, Jin Y and Wu Y: miR-34a regulates cisplatin-induce gastric
cancer cell death by modulating PI3K/AKT/survivin pathway. Tumour
Biol. 35:1287–1295. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang XP, Zhou J, Han M, Chen CB, Zheng YT,
He XS and Yuan XP: MicroRNA-34a regulates liver regeneration and
the development of liver cancer in rats by targeting Notch
signaling pathway. Oncotarget. 8:13264–13276. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kidd S, Lockett TJ and Young MW: The Notch
locus of Drosophila melanogaster. Cell. 34:421–433. 1983.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xiao W, Chen X and He M: Inhibition of the
Jagged/Notch pathway inhibits retinoblastoma cell proliferation via
suppressing the PI3K/Akt, Src, p38MAPK and Wnt/β catenin signaling
pathways. Mol Med Rep. 10:453–458. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li X, Yang L, Shuai T, Piao T and Wang R:
MiR-433 inhibits retinoblastoma malignancy by suppressing Notch1
and PAX6 expression. Biomed Pharmacother. 82:247–255. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nam JW, Rissland OS, Koppstein D,
Abreu-Goodger C, Jan CH, Agarwal V, Yildirim MA, Rodriguez A and
Bartel DP: Global analyses of the effect of different cellular
contexts on microRNA targeting. Mol Cell. 53:1031–1043. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Faucher JL, Lacronique-Gazaille C, Frébet
E, Trimoreau F, Donnard M, Bordessoule D, Lacombe F and Feuillard
J: “6 markers/5 colors” extended white blood cell differential by
flow cytometry. Cytometry A. 71:934–944. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Castro-Magdonel BE, Orjuela M, Camacho J,
García-Chéquer AJ, Cabrera-Muñoz L, Sadowinski-Pine S,
Durán-Figueroa N, Orozco-Romero MJ, Velázquez-Wong AC,
Hernández-Ángeles A, et al: miRNome landscape analysis reveals a 30
miRNA core in retinoblastoma. BMC Cancer. 17:4582017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Montoya V, Fan H, Bryar PJ, Weinstein JL,
Mets MB, Feng G, Martin J, Martin A, Jiang H and Laurie NA: Novel
miRNA-31 and miRNA-200a-Mediated Regulation of Retinoblastoma
Proliferation. PLoS One. 10:e01383662015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lodygin D, Tarasov V, Epanchintsev A,
Berking C, Knyazeva T, Körner H, Knyazev P, Diebold J and Hermeking
H: Inactivation of miR-34a by aberrant CpG methylation in multiple
types of cancer. Cell Cycle. 7:2591–2600. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang X, Xie Y and Wang J: Overexpression
of MicroRNA-34a-5p Inhibits Proliferation and Promotes Apoptosis of
Human Cervical Cancer Cells by Downregulation of Bcl-2. Oncol Res.
26:977–985. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kwon H, Song K, Han C, Zhang J, Lu L, Chen
W and Wu T: Epigenetic Silencing of miRNA-34a in Human
Cholangiocarcinoma via EZH2 and DNA Methylation: Impact on
Regulation of Notch Pathway. Am J Pathol. 187:2288–2299. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang X, Ai F, Li X, Tian L, Wang X, Shen
S and Liu F: MicroRNA-34a suppresses colorectal cancer metastasis
by regulating Notch signaling. Oncol Lett. 14:2325–2333. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Deng X, Zheng H, Li D, Xue Y, Wang Q, Yan
S, Zhu Y and Deng M: MicroRNA-34a regulates proliferation and
apoptosis of gastric cancer cells by targeting silent information
regulator 1. Exp Ther Med. 15:3705–3714. 2018.PubMed/NCBI
|
|
32
|
Ponnurangam S, Dandawate PR, Dhar A,
Tawfik OW, Parab RR, Mishra PD, Ranadive P, Sharma R, Mahajan G,
Umar S, et al: Quinomycin A targets Notch signaling pathway in
pancreatic cancer stem cells. Oncotarget. 7:3217–3232. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ke X, Zhao Y, Lu X, Wang Z, Liu Y, Ren M,
Lu G, Zhang D, Sun Z, Xu Z, et al: TQ inhibits hepatocellular
carcinoma growth in vitro and in vivo via repression of Notch
signaling. Oncotarget. 6:32610–32621. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mitter D, Ullmann R, Muradyan A,
Klein-Hitpass L, Kanber D, Ounap K, Kaulisch M and Lohmann D:
Genotype-phenotype correlations in patients with retinoblastoma and
interstitial 13q deletions. Eur J Hum Genet. 19:947–958. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lindsell CE, Boulter J, diSibio G, Gossler
A and Weinmaster G: Expression patterns of Jagged, Delta1, Notch1,
Notch2, and Notch3 genes identify ligand-receptor pairs that may
function in neural development. Mol Cell Neurosci. 8:14–27. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bao ZZ and Cepko CL: The expression and
function of Notch pathway genes in the developing rat eye. J
Neurosci. 17:1425–1434. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Asnaghi L, Tripathy A, Yang Q, Kaur H,
Hanaford A, Yu W and Eberhart CG: Targeting Notch signaling as a
novel therapy for retinoblastoma. Oncotarget. 7:70028–70044. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Pang RT, Leung CO, Ye TM, Liu W, Chiu PC,
Lam KK, Lee KF and Yeung WS: MicroRNA-34a suppresses invasion
through downregulation of Notch1 and Jagged1 in cervical carcinoma
and choriocarcinoma cells. Carcinogenesis. 31:1037–1044. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Li WB, Ma MW, Dong LJ, Wang F, Chen LX and
Li XR: MicroRNA-34a targets notch1 and inhibits cell proliferation
in glioblastoma multiforme. Cancer Biol Ther. 12:477–483. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang Z, Wang W, Huang K, Wang Y, Li J and
Yang X: MicroRNA-34a inhibits cells proliferation and invasion by
downregulating Notch1 in endometrial cancer. Oncotarget.
8:111258–111270. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Jo DH, Lee K and Kim JH, Jun HO, Kim Y,
Cho YL, Yu YS, Min JK and Kim JH: L1 increases adhesion-mediated
proliferation and chemoresistance of retinoblastoma. Oncotarget.
8:15441–15452. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Rao R and Honavar SG: Retinoblastoma.
Indian J Pediatr. 84:937–944. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Saakyan SV, Tsygankov АY, Moiseeva NI,
Karamysheva АF, Zhil'tsova MG and Tadevosyan SS: Retinoblastoma
Cell Culturing and Evaluation of Their Drug Resistance. Bull Exp
Biol Med. 165:148–153. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yang G, Fu Y, Lu X, Wang M, Dong H and Li
Q: miR 34a regulates the chemosensitivity of retinoblastoma cells
via modulation of MAGE A/p53 signaling. Int J Oncol. 54:177–187.
2019.PubMed/NCBI
|
|
45
|
Liu K, Huang J, Xie M, Yu Y, Zhu S, Kang
R, Cao L, Tang D and Duan X: MIR34A regulates autophagy and
apoptosis by targeting HMGB1 in the retinoblastoma cell. Autophagy.
10:442–452. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kang L, Mao J, Tao Y, Song B, Ma W, Lu Y,
Zhao L, Li J, Yang B and Li L: MicroRNA-34a suppresses the breast
cancer stem cell-like characteristics by downregulating Notch1
pathway. Cancer Sci. 106:700–708. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Li XJ, Ji MH, Zhong SL, Zha QB, Xu JJ,
Zhao JH and Tang JH: MicroRNA-34a modulates chemosensitivity of
breast cancer cells to adriamycin by targeting Notch1. Arch Med
Res. 43:514–521. 2012. View Article : Google Scholar : PubMed/NCBI
|
